Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor therapy, representing a potential advance in addressing excess weight. Early research findings have https://giantescapebike961328.wikitidings.com/7649310/retatrutide_in_australia_a_potential_hope_for_obesity_management